Fungal Keratitis
10
1
1
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
20.0%
2 terminated out of 10 trials
75.0%
-11.5% vs benchmark
40%
4 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction
Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL)
Collagen Cross-linking in Infectious Keratitis Trial
A Clinical Trial of the Treatment of Fungal Corneal Ulcers With Povidone-Iodine